These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1652716)
1. Alterations in opiate receptor binding in MPTP-induced hemiparkinsonian monkeys. Porrino LJ; Viola JJ; Crane AM; Pontieri FE Neurosci Lett; 1991 Jun; 127(2):155-9. PubMed ID: 1652716 [TBL] [Abstract][Full Text] [Related]
2. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys. Rioux L; Frohna PA; Joyce JN; Schneider JS Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972 [TBL] [Abstract][Full Text] [Related]
3. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex. Calon F; Goulet M; Blanchet PJ; Martel JC; Piercey MF; Bédard PJ; Di Paolo T Brain Res; 1995 May; 680(1-2):43-52. PubMed ID: 7663983 [TBL] [Abstract][Full Text] [Related]
4. Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density. Joyce JN; Marshall JF; Bankiewicz KS; Kopin IJ; Jacobowitz DM Brain Res; 1986 Sep; 382(2):360-4. PubMed ID: 2944565 [TBL] [Abstract][Full Text] [Related]
5. In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis. Skirboll S; Wang J; Mefford I; Hsiao J; Bankiewicz KS Exp Neurol; 1990 Nov; 110(2):187-93. PubMed ID: 1699780 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys. Hayase N; Tomiyoshi K; Watanabe K; Horikoshi S; Shibasaki T; Ohye C Ann Nucl Med; 1995 Aug; 9(3):119-23. PubMed ID: 8534583 [TBL] [Abstract][Full Text] [Related]
7. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients. Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656 [TBL] [Abstract][Full Text] [Related]
8. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study. Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947 [TBL] [Abstract][Full Text] [Related]
9. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism. Frohna PA; Rothblat DS; Joyce JN; Schneider JS Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343 [TBL] [Abstract][Full Text] [Related]
10. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Pifl C; Schingnitz G; Hornykiewicz O Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053 [TBL] [Abstract][Full Text] [Related]
11. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease. Pifl C; Schingnitz G; Hornykiewicz O Neurosci Lett; 1988 Oct; 92(2):228-33. PubMed ID: 3263594 [TBL] [Abstract][Full Text] [Related]
12. Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates. Soghomonian JJ; Pedneault S; Audet G; Parent A J Neurosci; 1994 Oct; 14(10):6256-65. PubMed ID: 7931578 [TBL] [Abstract][Full Text] [Related]
13. Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites. Przedborski S; Jackson-Lewis V; Popilskis S; Kostic V; Levivier M; Fahn S; Cadet JL Neurochirurgie; 1991; 37(6):377-82. PubMed ID: 1780015 [TBL] [Abstract][Full Text] [Related]
14. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys. Miletich RS; Bankiewicz KS; Quarantelli M; Plunkett RJ; Frank J; Kopin IJ; Di Chiro G Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225 [TBL] [Abstract][Full Text] [Related]
15. Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTP. Brooks BA; Eidelberg E; Morgan WW Brain Res; 1987 Sep; 419(1-2):329-32. PubMed ID: 3499952 [TBL] [Abstract][Full Text] [Related]
16. Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys. Guttman M; Yong VW; Kim SU; Calne DB; Martin WR; Adam MJ; Ruth TJ Synapse; 1988; 2(5):469-73. PubMed ID: 3263709 [TBL] [Abstract][Full Text] [Related]
17. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography. Robertson RG; Clarke CA; Boyce S; Sambrook MA; Crossman AR Brain Res; 1990 Oct; 531(1-2):95-104. PubMed ID: 2289139 [TBL] [Abstract][Full Text] [Related]
18. Selective metabolic activation by apomorphine in striosomes of denervated striatum in MPTP-induced hemiparkinsonian monkeys. Pontieri FE; Viola JJ; Sokoloff L; Porrino LJ Neuroreport; 1995 Jun; 6(9):1330-2. PubMed ID: 7669997 [TBL] [Abstract][Full Text] [Related]
19. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy. Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606 [TBL] [Abstract][Full Text] [Related]
20. Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors. Gagnon C; Gomez-Mancilla B; Bédard PJ; Di Paolo T Neurosci Lett; 1993 Nov; 163(1):31-5. PubMed ID: 7905197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]